Covalent backs AML Analytics to scale AI-powered financial crime testing
What's the deal? AML AnalyticsDealroom has a profile for this one. Try Dealroom → (AMLA), a UK-based RegTech specialising in independent testing and validation of financial crime defences, has raised growth equity from Covalent Equity Partners, which led the round. The investment was announced on October 28, 2026; terms were not disclosed.
What does AMLA do? Founded in 2010, the company evaluates whether anti-money-laundering (AML) systems actually work, supplying regulators and banks with benchmarks to measure and tune their controls. It serves more than 50 supervisory authorities and over 1,450 financial institutions across nearly 60 countries.
What's the money for? Covalent's capital will fund AMLA's engineering roadmap, next-generation testing engines, and global expansion. Founder Justin Holder stays on as group chief executive officer alongside the existing leadership team.
Why now? Regulators are shifting focus to whether AML controls work in practice, not just on paper. The Financial Conduct Authority highlighted that change in October, while a US Financial Crimes Enforcement Network proposal would retain independent testing and target program effectiveness — a direction that supports demand for AMLA's niche.
What Covalent says: "AMLA represents exactly what Covalent was created to back: a mission-critical platform with a strong data moat, made even stronger by AI," said co-founder and managing partner John Woyton. Fellow co-founder Quinlan Fang added that "AI is supercharging the growth of financial crime's surface area, outpacing the defenses built to contain it."
Miami-based Covalent, which also has a San Francisco hub, positions itself as a private equity firm built for the AI era, citing more than $8 billion in cumulative transaction value. FT Partners advised AMLA; Mills & Reeve and McGuireWoods served as legal counsel to AMLA and Covalent respectively.
The signal: Capital is flowing toward AI-driven compliance — Paris-based Marble raised €6.5 million in September to automate AML and fraud workflows. The Covalent deal is a bet on the inverse: as automated finance widens the attack surface, independent verification of the defences becomes its own growth market.
Read more: streetinsider.com
Image credit: Generated with Gemini
